AF
REPL icon

Amalgamated Financial’s Replimune Group REPL Stock Holding History

Amalgamated Financial’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$76K Buy
+4,463
New +$84.2K ﹤0.01% 2254

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Financial's REPL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Replimune Group (REPL) in Q1 2022: 4,463 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings.

107 funds tracked by Wall St. Rank hold REPL as of Q1 2022.

  • Amalgamated Financial held 4,463 shares of Replimune Group worth $76K as of Q1 2022.
  • Replimune Group was a new Amalgamated Financial position in Q1 2022.
  • Replimune Group made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2254 holding.
  • 107 funds tracked by Wall St. Rank held Replimune Group as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.